Hello all longs. I've been following the board but have not posted as of late, so long time no see. I would like to say a few things that have been on my mind for the past few weeks and with all the frenzy recently it seems the puzzle pieces I assembled seem to make more sense fitting together.
First off a little background...
- the data of ELI-200, and assembly thereof is pristine, at least from what I have reviewed with my doctoral background in pharmaceuticals. Also, Nasrat stated that we have been in constant communication with the FDA along every step of the way, even after our acceptance of the priority review and we have some top guns under our wings.
- priority reviews almost always get approved without an intervention based on statistics and if we were to get an ADCOM, we likely would have been notified early this month. A CRL is very unlikely to occur at this point especially because of priority review. But then again neither of these are completely out of the question.
Next Some HMMMMs (IMO)...
- 32-34 cents seems to be a golden range that we are always pulled back to, no matter down or up. We see the battle it takes to go higher with MM's selling tiny lots to bring it down, while taking huge sums to bring the stock up if any.
- look at the volatility today and the short sales for the past three days, and you'll see it is quite staggering (yes I know its not the monthly FINRA data but its the daily short volume that they can fix and change before reporting it) to hold us in this range even on the positive movement days we barely broke through the bollinger upper band
- DOES ANYONE REMEMBER THE SHARES THAT WERE REGISTERED TO BE SOLD LAST MONTH? the LPC deal we have also allowed them to sell millions on the open market at a perceived value of a little above 32 cents.
- DOES ANYONE REMEMBER THE DOCUMENTS THAT WERE JUST RELEASED A FEW DAYS AGO? The CT doc and the 10k/a are very telling towards an approval and more, hence the pediatric study addition to be completed, after acceptance, paid by profits from both entities.
Lastly, my input (all IMO)
Could it be possible that we are going to get approval and then move very quickly towards a finalization of a buyout or submission and licensing plans of the next ELI's? Some of the 10k/a statements were left out plus that CT doc for info to be released by December. It's all very telling of approval tomorrow, or a minor change like semantics on labeling, annd receipt of approval in the very near future.
Connecting it all, maybe the LPC shares were to be registered to keep us in this range during all the excitement of this very novel treatment of pain, as buyouts are always based off the current value of the share price and potential future upside. Shorting the stock with these shares to keep us range bound for an XX multiplier of our current share price to give a share price for a buyout?
Approval and buyout are imminent, I just believe and hope for sooner rather than later.
